Last reviewed · How we verify
Hiltonol and autologous dendritic cells — Competitive Intelligence Brief
phase 2
Biologic
Live · refreshed every 30 min
Target snapshot
Hiltonol and autologous dendritic cells (Hiltonol and autologous dendritic cells) — Clinica Universidad de Navarra, Universidad de Navarra.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Hiltonol and autologous dendritic cells TARGET | Hiltonol and autologous dendritic cells | Clinica Universidad de Navarra, Universidad de Navarra | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Hiltonol and autologous dendritic cells CI watch — RSS
- Hiltonol and autologous dendritic cells CI watch — Atom
- Hiltonol and autologous dendritic cells CI watch — JSON
- Hiltonol and autologous dendritic cells alone — RSS
Cite this brief
Drug Landscape (2026). Hiltonol and autologous dendritic cells — Competitive Intelligence Brief. https://druglandscape.com/ci/hiltonol-and-autologous-dendritic-cells. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab